Inventor
WHATCOTT CLIFFORD J
US9 patents
⚠️ This page may combine multiple inventors who share the name “WHATCOTT CLIFFORD J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TOLERO PHARMACEUTICALS INC
5 patentsUS10267787B2Apr 23, 2019
Profiling peptides and methods for sensitivity profiling
TOLERO PHARMACEUTICALS INC13 citations91
US10132797B2Nov 20, 2018
Profiling peptides and methods for sensitivity profiling
TOLERO PHARMACEUTICALS INC15 citations91
US10682356B2Jun 16, 2020
Combination therapies for treatment of cancer
TOLERO PHARMACEUTICALS INC7 citations84
US10568887B2Feb 25, 2020
Combination therapies for treatment of cancer
TOLERO PHARMACEUTICALS INC10 citations84
US10422788B2Sep 24, 2019
Profiling peptides and methods for sensitivity profiling
TOLERO PHARMACEUTICALS INC11 citations82
SUMITOMO DAINIPPON PHARMA ONCOLOGY INC
2 patentsUS10835537B2Nov 17, 2020
Combination therapies for treatment of cancer
SUMITOMO DAINIPPON PHARMA ONCOLOGY INC7 citations83
US11040038B2Jun 22, 2021
Methods for treating diseases associated with abnormal ACVR1 expression and ACVR1 inhibitors for use in the same
SUMITOMO DAINIPPON PHARMA ONCOLOGY INC1 citations59
SUMITOMO PHARMA ONCOLOGY INC
2 patentsUS11497756B2Nov 15, 2022
Treatment regimen for cancers that are insensitive to BCL-2 inhibitors using the MCL-1 inhibitor alvocidib
SUMITOMO PHARMA ONCOLOGY INC4 citations72
US11529350B2Dec 20, 2022
Tyrosine kinase non-receptor 1 (TNK1) inhibitors and uses thereof
SUMITOMO PHARMA ONCOLOGY INC0 citations51